Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon

BACKGROUND: Coinfection with hepatitis B virus (HBV) or hepatitis C virus (HCV) in HIV-infected patients receiving a commonly used nevirapine-based antiretroviral therapy is a major concern for African clinicians owing to its high prevalence, the infrequent testing and treatment of viral hepatitis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mbougua, Jules B Tchatchueng, Laurent, Christian, Kouanfack, Charles, Bourgeois, Anke, Ciaffi, Laura, Calmy, Alexandra, Gwet, Henri, Koulla-Shiro, Sinata, Ducos, Jacques, Mpoudi-Ngolé, Eitel, Molinari, Nicolas, Delaporte, Eric
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841671/
https://www.ncbi.nlm.nih.gov/pubmed/20193053
http://dx.doi.org/10.1186/1471-2458-10-105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841671/
https://www.ncbi.nlm.nih.gov/pubmed/20193053
http://dx.doi.org/10.1186/1471-2458-10-105

Ejemplares similares